These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 17292994

  • 1. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders.
    Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Pérez-Bravo F.
    Diabetes Res Clin Pract; 2007 Aug; 77(2):245-50. PubMed ID: 17292994
    [Abstract] [Full Text] [Related]

  • 2. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile.
    Pérez-Bravo F, Fuentes M, Angel B, Sanchez H, Carrasco E, Santos JL, Lera L, Albala C.
    Acta Diabetol; 2006 Dec; 43(4):93-8. PubMed ID: 17211557
    [Abstract] [Full Text] [Related]

  • 3. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians.
    Vimaleswaran KS, Radha V, Mohan V.
    Metabolism; 2006 Sep; 55(9):1222-6. PubMed ID: 16919542
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2.
    De Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R, De la Fuente B.
    Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):89-95. PubMed ID: 20329566
    [Abstract] [Full Text] [Related]

  • 7. Association between functional FABP2 promoter haplotype and type 2 diabetes.
    Li Y, Fisher E, Klapper M, Boeing H, Pfeiffer A, Hampe J, Schreiber S, Burwinkel B, Schrezenmeir J, Döring F.
    Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625
    [Abstract] [Full Text] [Related]

  • 8. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
    Aller R, De Luis DA, Fernandez L, Calle F, Velayos B, Izaola O, Gonzalez Sagrado M, Conde R, Gonzalez JM.
    Eur Rev Med Pharmacol Sci; 2009 May; 13(5):357-64. PubMed ID: 19961041
    [Abstract] [Full Text] [Related]

  • 9. Intestinal fatty acid binding protein Ala54Thr polymorphism is associated with peripheral atherosclerosis combined with type 2 diabetes mellitus.
    Khattab SA, Abo-Elmatty DM, Ghattas MH, Mesbah NM, Mehanna ET.
    J Diabetes; 2017 Sep; 9(9):821-826. PubMed ID: 27778448
    [Abstract] [Full Text] [Related]

  • 10. Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men.
    Ishii T, Hirose H, Kawai T, Hayashi K, Maruyama H, Saito I, Saruta T.
    Metabolism; 2001 Nov; 50(11):1301-7. PubMed ID: 11699048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort.
    Fisher E, Li Y, Burwinkel B, Kühr V, Hoffmann K, Möhlig M, Spranger J, Pfeiffer A, Boeing H, Schrezenmeir J, Döring F.
    Horm Metab Res; 2006 May; 38(5):341-5. PubMed ID: 16718632
    [Abstract] [Full Text] [Related]

  • 13. Effect of Ala54Thr polymorphism of FABP2 on anthropometric and biochemical variables in response to a moderate-fat diet.
    Martinez-Lopez E, Garcia-Garcia MR, Gonzalez-Avalos JM, Maldonado-Gonzalez M, Ruiz-Madrigal B, Vizmanos B, Hernandez-Nazara Z, Roman S, Panduro A.
    Nutrition; 2013 Jan; 29(1):46-51. PubMed ID: 22817827
    [Abstract] [Full Text] [Related]

  • 14. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C, Botnia Research Group.
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [Abstract] [Full Text] [Related]

  • 15. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M, Nicholls MG.
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [Abstract] [Full Text] [Related]

  • 16. Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina.
    Gomez LC, Real SM, Ojeda MS, Gimenez S, Mayorga LS, Roqué M.
    BMC Med Genet; 2007 Jun 26; 8():39. PubMed ID: 17594477
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Higher cardiorespiratory fitness attenuates arterial stiffening associated with the Ala54Thr polymorphism in FABP2.
    Fujie S, Iemitsu M, Murakami H, Sanada K, Kawano H, Gando Y, Kawakami R, Miyachi M.
    Physiol Genomics; 2013 Mar 18; 45(6):237-42. PubMed ID: 23362142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.